CGNH logo

CardioGenics Holdings Inc Stock Price

OTCPK:CGNH Community·US$142.0 Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

CGNH Share Price Performance

US$0.000001
-0.00 (-99.00%)
US$0.000001
-0.00 (-99.00%)
Price US$0.000001

CGNH Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

CardioGenics Holdings Inc Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$980.8k

Other Expenses

-US$980.8k

Earnings

Last Reported Earnings
Jan 31, 2016
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About CGNH

Founded
1997
Employees
n/a
CEO
Yahia Gawad
WebsiteView website
www.cardiogenics.com

CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market. Its products include QL Care Analyzer, which is a portable, stand-alone, and automated POC immunoanalyzer; a series of immunoassay tests to enhance the management of patients with cardiovascular diseases; and paramagnetic beads that are used as a solid surface in medical laboratories’ immunoassay testing equipment. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was incorporated in 1997 and is based in Mississauga, Canada.

Recent CGNH News & Updates

No updates

Recent updates

No updates